News

We are thrilled to announce that avisé labs has once again been recognized as one of the best German employers in 2025 in the category of companies with up to 100 employees. 

Handelsblatt, together with the market research institute SWI Human Resources (SWI HR), evaluated nearly 2,000 companies across Germany based on diversity, equal opportunities, freedom from discrimination, fair career advancement, and employee-friendly measures such as flexible working options and remote work policies. Companies were surveyed on their strategies and initiatives in these areas, and the results were scored to determine the ranking.

According to this ranking, avisé labs continues to stand out as one of the best employers of 2025! We are deeply grateful to work with such a talented team and to collaborate with wonderful partners and customers.

Read the article here: https://www.handelsblatt.com/unternehmen/ranking-das-sind-deutschlands-beste-arbeitgeber-des-jahres-2025/100155599.html

News

We are excited to announce that Avisé Labs has once again been recognized as part of the prestigious AI Startup Landscape, published by the appliedAI Institute for Europe!
This recognition is a great honor for us — and a strong confirmation of our work and commitment to advancing AI.

Germany on its way to becoming an AI nation 

The newly released AI Startup Landscape 2025 highlights the impressive growth and resilience of the German AI startup ecosystem:

• 📈 +36% growth in the number of AI startups compared to last year

• 💡 >90% survival rate – thanks in part to bootstrapping, German AI startups are exceptionally resilient

• 🤖 +130% increase in GenAI startups – Generative AI is booming

• 💶 Nearly 200% growth in early-stage funding

• 🌆 AI Cities: Berlin & Munich remain in the lead, while Hamburg, Cologne, Karlsruhe, Stuttgart, Frankfurt, Darmstadt, Aachen, Düsseldorf, and Tübingen are rapidly catching up

Another striking development: for the first time, the number of platform developers has surpassed that of pure application developers — a clear sign that German startups are increasingly building the foundations for scalable AI.

Read the full analysis here: https://www.appliedai-institute.de/hub/2025-deutsche-ki-startup-landscape
Read the WirtschaftsWoche article here: https://nachrichten.wiwo.de/843305afe9eae4ad41c41b7bc1c2357e3206c606d2c4f7a766deea07d7cecd95699b74b4a14dd2bcb226c71236e01cc91100151532
Read the Handelsblatt article here: https://www.handelsblatt.com/technik/ki/ki-ist-aleph-alpha-keines-der-vielversprechendsten-ki-start-ups-mehr/100150471.html 

News

With the EU AI Act now in effect, member states should establish AI regulatory sandboxes by 2026 – spaces that allow for the testing of AI systems under real-world conditions with legal flexibility and close cooperation with regulators.

In a new discussion paper by the appliedAI Institute for Europe gGmbH, seven key conditions for effective AI sandboxes are outlined. The goal: to create environments that enable innovation while ensuring oversight – especially for startups and SMEs.

At avisé labs, we were pleased to contribute to this important dialogue. Our co-founder Marius Khan was interviewed for the paper, sharing our experience as an early-
stage AI startup navigating regulatory uncertainty.

The publication emphasizes that regulation should not be a roadblock, but part of an adaptive ecosystem that evolves alongside technology. For companies like avisé labs, AI sandboxes can become a vital tool for responsible experimentation, faster learning, and trust-building with users and regulators alike.

📄 Read the full paper (in German and the interview in English):
https://www.appliedai-institute.de/hub/policy-brief-regulatory-sandbox

We thank the team at appliedAI – especially Demian Niemeyer, Lajla Fetic and Dr. Till Klein – for including us in this initiative, and we look forward to continued engagement on how AI regulation can become a driver for innovation rather than a barrier.

---

 

News

This symposium provides a valuable and important platform for inspiring interdisciplinary exchange at the forefront of drug research and will support a fantastic networking experience. It provides a great resource for researchers, pharmaceutical companies, investment groups, and those in the wider biomedical community interested in discovering new drugs and improving patient care. We look forward to an exciting two days of talks and discussion.   

Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute

We’re excited to share that Avisé Labs will be attending the 2025 Stanford Drug Discovery Symposium in person! As we continue to push the boundaries of intelligent software-driven innovations in medicine and pharmaceuticals, we’re eager to connect with like-minded pioneers and explore new partnerships.

Will you be there? Let’s connect at Stanford and shape the future of drug discovery together!

News

We are proud to be among the best German employers of 2024 in the category of companies with up to 100 employees. And by the way, we are the only ones in this category in the medical technology sector 🙂

Handelsblatt, together with the market research institute SWI Human Resources (SWI HR), examined how companies are positioned in terms of diversity, equal opportunities, and freedom from discrimination. Criteria for fair career advancement were investigated, with nearly 2000 companies surveyed about strategies and measures and evaluated with points.

According to this ranking, avisé labs is among the best employers of 2024!We are infinitely grateful to be able to work with such a great team and such wonderful partners and customers.

You can read the article in today’s print version of Handelsblatt

or here: https://media.handelsblatt.com/handelsblatt/downloads/2024/Handelsblatt_Beste_Arbeitgeber_2024.pdf

The online article is here:

https://www.handelsblatt.com/karriere/karriere-diese-unternehmen-sind-vorreiter-in-sachen-vielfalt/100076047.html

News

We are excited to share that avisé labs has published a new research paper in the Journal of Cosmetic Dermatology, in collaboration with our esteemed international partners.
The paper „AI in Aesthetic/Cosmetic Dermatology: Current and Future“ discusses current trends, challenges and future directions of applying AI in dermatology. 

You can access the paper here: 
J of Cosmetic Dermatology – 2024 – Thunga – AI in Aesthetic Cosmetic Dermatology Current and Future

News

In a recent conversation, Jane Yoo, MD, a leading dermatologist in New York City, and our CEO Marius Khan discussed the rising influence of artificial intelligence (AI) in dermatology and medicine.

This interview is printed in the February-March 2024 issue of Modern Aesthetics, accessible at

https://modernaesthetics.com/articles/2024-jan-feb/the-art-of-software-design-in-dermatology-and-aesthetic-medicine/pdf 

You can download the PDF also HERE

News

This symposium provides a valuable and important platform for inspiring interdisciplinary exchange at the forefront of drug research and will support a fantastic networking experience. It provides a great resource for researchers, pharmaceutical companies, investment groups, and those in the wider biomedical community interested in discovering new drugs and improving patient care. We look forward to an exciting two days of talks and discussion.   

Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute

avisé labs is also attending this event in person in 2024 to establish new partnerships for innovative medical applications fostered by intelligent software approaches. We are looking forward to connecting with you at Stanford!

Link to the conference:

https://med.stanford.edu/cvi/events/2024-drug-discovery-conference.html